Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis.

MLA

Prosperini, Luca, et al. “Minimal Evidence of Disease Activity (MEDA) in Relapsing-Remitting Multiple Sclerosis.” Journal of Neurology, Neurosurgery & Psychiatry, vol. 91, no. 3, Mar. 2020, pp. 271–77. EBSCOhost, https://doi.org/10.1136/jnnp-2019-322348.

APA

Prosperini, L., Mancinelli, C., Haggiag, S., Cordioli, C., De Giglio, L., De Rossi, N., Galgani, S., Rasia, S., Ruggieri, S., Tortorella, C., Pozzilli, C., & Gasperini, C. (2020). Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, 91(3), 271–277. https://doi.org/10.1136/jnnp-2019-322348

Chicago

Prosperini, Luca, Chiara Mancinelli, Shalom Haggiag, Cinzia Cordioli, Laura De Giglio, Nicola De Rossi, Simonetta Galgani, et al. 2020. “Minimal Evidence of Disease Activity (MEDA) in Relapsing-Remitting Multiple Sclerosis.” Journal of Neurology, Neurosurgery & Psychiatry 91 (3): 271–77. doi:10.1136/jnnp-2019-322348.